Caricamento...
Treating cancer when pRb and p53 cannot be reactivated
Activation of oncoproteins and inactivation of tumor suppressors induces tumorigenesis. When these events happen upstream of pRb and p53, cancer therapies may initially succeed and then fail when pRb and p53 are activated and then re-inactivated. Therapies might succeed if they remain effective when...
Salvato in:
| Pubblicato in: | Mol Cell Oncol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905341/ https://ncbi.nlm.nih.gov/pubmed/27308498 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1004954 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|